Skip to Main Content

Paper Details

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
Clin Infect Dis
61
2021
Infants, LRTI, MARI, RSV, RSV A, RSV B, RSV MARI, Respiratory Syncytial Virus Infection, Respiratory syncytial virus, Suptavumab, amino acid, childhood, human, infants, lower respiratory tract infection, medically attended respiratory infection, suptavumab, suptavumab epitope
Author NameAffiliation
Alicia Hawes
Alicia Hawes
Jason S McLellanUniversity of Texas at Austin
George D YancopoulosRegeneron Pharmaceuticals
  • 1 - 4

Datasets

Release 1.2